Study Links Private-Label OTC Purchases To Pharma Knowledge
This article was originally published in The Tan Sheet
Executive Summary
Physicians and pharmacists are significantly more likely than average consumers to purchase private-label OTC headache remedies, a marketing study finds. The researchers say brands in categories with largely homogenous products may derive premiums through “misinformation” in advertising.
You may also be interested in...
Perrigo Campaigns For Rational OTC Shopping Over Brand Loyalty
The online “Store Brand Meds” campaign launched by Perrigo in early 2013 encourages consumers to “Make store brands your brand,” by emphasizing lower price points and equivalent active ingredients. Overcoming consumer connections to brands such as Tylenol is a challenge, however.
Bayer Advances Aspirin Pain Relief With Pro-Release Technology
Bayer HealthCare unveils Bayer Advanced Aspirin, the company's latest innovation geared toward keeping its century-old pain relief brand fresh.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.